Folate receptor

Ongoing clinical trials and approved products targeting Folate receptor, in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.

0ongoing therapy trials

4ongoing imaging trials

0approved products

Target note

Full name: Folate receptor
Nature: Membrane receptor for folic acid.
Normal expression: Kidneys, activated macrophages.
Value: Imaging FRα-positive cancers and activated macrophages.
Approaches: [18F]AlF-NOTA-folate.
Indications explored: Ovarian and lung cancers; inflammation (research).
Points of caution: Renal uptake.

Ongoing imaging trials · 4Open in the radar →

Trial	Phase	Status	Sponsor	Countries
Folate receptor tracers2024-513537-21-02 · Inflammatory diseases	Phase 2	Recruiting	Amsterdam UMC Stichting	1
Folate receptor tracers2024-514491-40-00 · Atherosclerosis and vessels	Phase 2	Recruiting	Universitair Medisch Centrum Groningen	1
FOL-CARD · Folate receptor tracersNCT07814222 · Heart failure and cardiomyopathies	No phase	Recruiting	Turku University Hospital	1
ATHERO-FOL · Folate receptor tracersNCT07877324 · Atherosclerosis and vessels	No phase	Recruiting	Turku University Hospital	1

Cite this page

Folate receptor. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/folate-receptor/ (accessed [date]).

A monitoring tool with no regulatory value: check every item at its source.